Sawadogo Bernard, Tint Khin San, Tshimanga Mufuta, Kuonza Lazarus, Ouedraogo Laurent
South Africa Field Epidemiology and Laboratory Training Programme, South Africa ; School of Health System and Public health: University of Pretoria, South Africa ; University of Ouagadougou, Burkina Faso.
South Africa Field Epidemiology and Laboratory Training Programme, South Africa ; School of Health System and Public health: University of Pretoria, South Africa.
Pan Afr Med J. 2015 Jun 24;21:152. doi: 10.11604/pamj.2015.21.152.4827. eCollection 2015.
In Burkina Faso, the tuberculosis (TB) treatment failure rate increased from 2.5% in 2000 to 8.3% in 2006. The risk factors for TB treatment failure in the country are not well known. The study aims to determine the risk factors for treatment failure among pulmonary tuberculosis patients in four health region of Burkina Faso and to recommend appropriate interventions.
A case control study was conducted among pulmonary TB patients who began TB treatment in 2009. A case was any patient who remained smear-positive at fifth month of TB treatment and a control was a patient who tested smear-negative at fifth month of treatment. A structured questionnaire was administered to one hundred cases and one hundred controls to collect information on exposure factors. Odds ratio were calculated using bivariate and multivariate analysis to determine the association between exposures and outcome.
Multivariate analysis showed that independent risk factors for TB treatment failure were fail to take TB drugs for more than 14 consecutive days (OR = 18.53; 95% CI:4.56 - 75.22), sputum smear-positive at two months of treatment (OR = 11.52; 95%CI:5.18-25.60), existence of comorbidity (OR = 5.74; 95%CI:1.69-19.44), and use of traditional medicines or herbs (OR = 2.97; 95%CI:1.12-7.85).
Early identification of patients with the above risk factors for intense case management will improve TB treatment outcome. Patient with smear positive at 2nd(nd) month of treatment require more intense follow-up, and involving traditional healers who provide traditional medicines or herbs in the educational programme on TB are required. The national referral laboratory capacity needs to be strengthened to do drug susceptibility testing and routine drug monitoring on cases of non conversion at 2(nd) month of treatment.
在布基纳法索,结核病治疗失败率从2000年的2.5%上升至2006年的8.3%。该国结核病治疗失败的风险因素尚不明确。本研究旨在确定布基纳法索四个健康区域肺结核患者治疗失败的风险因素,并提出适当的干预措施。
对2009年开始接受结核病治疗的肺结核患者进行病例对照研究。病例为结核病治疗第五个月痰涂片仍呈阳性的患者,对照为治疗第五个月痰涂片检测呈阴性的患者。向100例病例和100例对照发放结构化问卷,收集暴露因素信息。采用双变量和多变量分析计算比值比,以确定暴露因素与结果之间的关联。
多变量分析显示,结核病治疗失败的独立风险因素包括连续14天以上未服用抗结核药物(比值比=18.53;95%置信区间:4.56 - 75.22)、治疗两个月时痰涂片阳性(比值比=11.52;95%置信区间:5.18 - 25.60)、存在合并症(比值比=5.74;95%置信区间:1.69 - 19.44)以及使用传统药物或草药(比值比=2.97;95%置信区间:1.12 - 7.85)。
早期识别具有上述风险因素的患者进行强化病例管理,将改善结核病治疗效果。治疗第二个月痰涂片阳性的患者需要更密切的随访,并且需要让提供传统药物或草药的传统治疗师参与结核病教育项目。需要加强国家转诊实验室的能力,以便对治疗第二个月未转阴的病例进行药物敏感性检测和常规药物监测。